Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Peptide T

Next Previous
Search
Drug Profile

Peptide T

Latest Information Update: 23 Sep 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Karolinska Institute; National Institutes of Health (USA)
  • Developer Advanced Immuni T
  • Class Anti-inflammatories; Antipsoriatics; Antivirals; Oligopeptides
  • Mechanism of Action CCR5 receptor antagonists; Immunomodulators; Tumour necrosis factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Alzheimer's disease; Cachexia; Chronic fatigue syndrome; Herpesvirus infections; HIV infections; Inflammatory bowel diseases; Multiple sclerosis; Polyomavirus infections; Psoriasis; Rheumatoid arthritis

Most Recent Events

  • 20 Aug 2004 Peptide T is available for licensing worldwide(http://www.advancedimmunit.com)
  • 20 Aug 2004 Phase-I/II clinical trials in Alzheimer's disease in Canada (Intranasal)
  • 20 Aug 2004 Phase-I/II clinical trials in Chronic fatigue syndrome in Canada (Intranasal)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top